Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide

M Wojtoniszak, X Chen, RJ Kalenczuk, A Wajda… - Colloids and Surfaces B …, 2012 - Elsevier
M Wojtoniszak, X Chen, RJ Kalenczuk, A Wajda, J Łapczuk, M Kurzewski, M Drozdzik
Colloids and Surfaces B: Biointerfaces, 2012Elsevier
The synthesis, characterization, and toxicity of graphene oxide and reduced graphene oxide
are reported. Prior to the cytocompatibility tests the stability of the suspensions in a wide
range of concentrations (3.125-100μg/mL) of three different dispersants is studied.
Polyethylene glycol (PEG), polyethylene glycol–polypropylene glycol–polyethylene glycol
(Pluronic P123), and sodium deoxycholate (DOC) are investigated as the dispersants. The
toxicity depends on the type of dispersant and concentration of the nanomaterials in the …
The synthesis, characterization, and toxicity of graphene oxide and reduced graphene oxide are reported. Prior to the cytocompatibility tests the stability of the suspensions in a wide range of concentrations (3.125-100μg/mL) of three different dispersants is studied. Polyethylene glycol (PEG), polyethylene glycol–polypropylene glycol–polyethylene glycol (Pluronic P123), and sodium deoxycholate (DOC) are investigated as the dispersants. The toxicity depends on the type of dispersant and concentration of the nanomaterials in the suspensions. Detailed analysis suggests that graphene oxide functionalized with PEG in the concentration range between 3125μg/mL and 25μg/mL exhibits the best biocompatibility with mice fibroblast cells (line L929).
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果